PortfoliosLab logo
FAT vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between FAT and LLY is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

FAT vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in FAT Brands Inc. (FAT) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%1,000.00%1,200.00%NovemberDecember2025FebruaryMarchApril
103.50%
1,011.60%
FAT
LLY

Key characteristics

Sharpe Ratio

FAT:

-0.53

LLY:

0.51

Sortino Ratio

FAT:

-0.43

LLY:

0.97

Omega Ratio

FAT:

0.93

LLY:

1.13

Calmar Ratio

FAT:

-0.54

LLY:

0.74

Martin Ratio

FAT:

-1.21

LLY:

1.52

Ulcer Index

FAT:

24.92%

LLY:

12.04%

Daily Std Dev

FAT:

57.26%

LLY:

36.19%

Max Drawdown

FAT:

-78.79%

LLY:

-68.27%

Current Drawdown

FAT:

-51.67%

LLY:

-10.14%

Fundamentals

Market Cap

FAT:

$44.59M

LLY:

$744.81B

EPS

FAT:

-$11.60

LLY:

$11.69

PS Ratio

FAT:

0.08

LLY:

16.54

PB Ratio

FAT:

12.81

LLY:

52.48

Total Revenue (TTM)

FAT:

$440.69M

LLY:

$36.27B

Gross Profit (TTM)

FAT:

$114.50M

LLY:

$29.53B

EBITDA (TTM)

FAT:

-$22.27M

LLY:

$12.51B

Returns By Period

In the year-to-date period, FAT achieves a -15.65% return, which is significantly lower than LLY's 11.56% return.


FAT

YTD

-15.65%

1M

-15.25%

6M

-9.40%

1Y

-31.86%

5Y*

41.46%

10Y*

N/A

LLY

YTD

11.56%

1M

0.87%

6M

-3.22%

1Y

18.18%

5Y*

41.34%

10Y*

30.82%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FAT vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FAT
The Risk-Adjusted Performance Rank of FAT is 2222
Overall Rank
The Sharpe Ratio Rank of FAT is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of FAT is 2626
Sortino Ratio Rank
The Omega Ratio Rank of FAT is 2424
Omega Ratio Rank
The Calmar Ratio Rank of FAT is 1818
Calmar Ratio Rank
The Martin Ratio Rank of FAT is 2020
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 7070
Overall Rank
The Sharpe Ratio Rank of LLY is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 6666
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 6464
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 8080
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FAT vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for FAT Brands Inc. (FAT) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for FAT, currently valued at -0.53, compared to the broader market-2.00-1.000.001.002.003.00
FAT: -0.53
LLY: 0.51
The chart of Sortino ratio for FAT, currently valued at -0.43, compared to the broader market-6.00-4.00-2.000.002.004.00
FAT: -0.43
LLY: 0.97
The chart of Omega ratio for FAT, currently valued at 0.93, compared to the broader market0.501.001.502.00
FAT: 0.93
LLY: 1.13
The chart of Calmar ratio for FAT, currently valued at -0.54, compared to the broader market0.001.002.003.004.005.00
FAT: -0.54
LLY: 0.74
The chart of Martin ratio for FAT, currently valued at -1.21, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
FAT: -1.21
LLY: 1.52

The current FAT Sharpe Ratio is -0.53, which is lower than the LLY Sharpe Ratio of 0.51. The chart below compares the historical Sharpe Ratios of FAT and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
-0.53
0.51
FAT
LLY

Dividends

FAT vs. LLY - Dividend Comparison

FAT's dividend yield for the trailing twelve months is around 9.36%, more than LLY's 0.63% yield.


TTM20242023202220212020201920182017201620152014
FAT
FAT Brands Inc.
9.36%10.53%9.25%10.92%4.91%0.00%6.37%18.89%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.63%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

FAT vs. LLY - Drawdown Comparison

The maximum FAT drawdown since its inception was -78.79%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for FAT and LLY. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-51.67%
-10.14%
FAT
LLY

Volatility

FAT vs. LLY - Volatility Comparison

FAT Brands Inc. (FAT) has a higher volatility of 20.70% compared to Eli Lilly and Company (LLY) at 18.73%. This indicates that FAT's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
20.70%
18.73%
FAT
LLY

Financials

FAT vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between FAT Brands Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items